Atlas Trials

Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection

Clinical trial NCT04784559 · TERMINATED

Trial details

NCT number
NCT04784559
Sponsor
PharmaMar
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19 Infection
Start date
2021-06-04
Primary completion
2023-03-01
Enrollment
205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.